Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702

Fig 2

Treatment schema for NABTT 0702 testing the single agent activity of AT-101 in patients with recurrent glioblastoma.

AT-101 administered 20 mg p.o. per day on days 1–21 of 28-day cycles until progression.

Fig 2

doi: https://doi.org/10.1371/journal.pone.0291128.g002